Neil Versel

In purchasing startup SolveBio, Precision for Medicine's QuartzBio saw an opportunity to augment its genomic and clinical data analytics during a growth phase.

Researchers at Barcelona's CNAG-CRG are assessing variants in rare disease patients by linking them to alignments of "slices" of genomes and exomes in the European Genome-Phenome Archive.

The software, described in a new paper and applied in another, uses an image-based convolutional neural network to help identify mosaic variants.

After dropping underdeveloped Sema4 business lines but emphasizing the Centrellis informatics platform, the new GeneDx expects to reach profitability by 2025.

The drug discovery and bioinformatics firm, which was recently chosen to be part of a Merck-supported accelerator program, believes that transomics is more integrated and comprehensive than multiomics.

The year saw significant progress in clinical and research areas, but vendors and healthcare providers continue to struggle with clinical decision support and interoperability.

Medical geneticists and bioinformaticians seek coding systems that can support accurate genotyping, disease causation, and reimbursement alike.

In the Instand-NGS4P program, a group of seven European hospitals are encouraging technology vendors to innovate by offering a path to IVDR compliance and a wide market for new products.

The health system, which has now enrolled 150,000 people in its population genomics program, has implemented its technology across CDC tier one conditions but has grander ambitions.

Amazon Web Services announced the new "purpose-built managed service" for multiomics data at its annual developer conference in Las Vegas.